参考:
[1] Cho S W, Kim S, Kim Y, et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases[J]. Genome research, 2014, 24(1): 132-141.
[2] Kleinstiver B P, Prew M S, Tsai S Q, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities[J]. Nature, 2015, 523(7561): 481.
[3] Terao M, Tamano M, Hara S, et al. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9[J]. Experimental animals, 2016, 65(3): 275-283.
[4] Müller M, Lee C M, Gasiunas G, et al. Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome[J]. Molecular Therapy, 2016, 24(3):636–644.
[5] Qi L, Larson M, Gilbert L, et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression[J]. Cell, 2013, 152(5):1173.
[6] Luke A. Gilbert, Matthew H. Larson, Morsut L, et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes[J]. Cell, 2013, 154(2):442.
[7] Hsu P D, Scott D A, Weinstein J A, et al. DNA targeting specificity of RNA-guided Cas9 nucleases[J]. Nature Biotechnology, 2013, 31(9):827-32.
[8] Fu Y, Sander J D, Reyon D, et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs[J]. Nature Biotechnology, 2014, 32(3):279.
[9] Kleinstiver B P, Vikram P, Prew M S, et al. High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets:[J]. Nature, 2016, 529(7587):490-495.
[10] Slaymaker I M, Gao L, Zetsche B, et al. Rationally engineered Cas9 nucleases with improved specificity[J]. Science, 2016, 351(6268):84.
[11] Chiang T W W, Sage C L, Larrieu D, et al. CRISPR-Cas9 D10A nickase-based genotypic and phenotypic
screening to enhance genome editing[J]. Scientific Reports, 2016, 6:24356.
[12] Pan Y, Shen N, Jungklawitter S, et al. CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model[J]. Scientific Reports, 2016, 6:35794.